Migami

Migami is a biotechnology company focused on developing next-generation live biotherapeutics and active ingredients derived from the human skin microbiome. The company utilizes its proprietary MIGAMI (Microbiome-Grown Active Microbial Ingredients) platform to identify and cultivate beneficial commensal bacteria that can restore skin health and treat inflammatory conditions. Their research primarily targets dermatological indications such as atopic dermatitis and acne by leveraging the natural protective functions of the microbiome. Migami aims to bridge the gap between traditional skincare and clinical dermatology through scientifically validated microbial solutions.